Clincosm LogoSign in Get a demo

advanced or metastatic solid tumors

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Solid Tumors Trial in Birtinya, Frankston (KGX101- Cohort 1, KGX101- Cohort 2, KGX101- Cohort 3)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • KGX101- Cohort 1
  • +7 more
  • Birtinya, Queensland, Australia
  • +1 more
Oct 3, 2023

Advanced or Metastatic Solid Tumors Trial (PMC-309 monotherapy, PMC-309 Dose Escalation in Combination with Pembrolizumab,

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PMC-309 monotherapy
  • +2 more
  • (no location specified)
Jul 19, 2023

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Advanced or Metastatic Solid Tumors Trial in Guangzhou (BAT8010 for Injection)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • BAT8010 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 27, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Advanced or Metastatic Solid Tumors Trial (DCSZ11)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Mar 14, 2023

Advanced or Metastatic Solid Tumors Trial (PRTH-101, Pembrolizumab)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PRTH-101
  • Pembrolizumab
  • (no location specified)
Feb 27, 2023

Advanced or Metastatic Solid Tumors Trial in United States (MDK-703, Checkpoint Inhibitor, Immune)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Sarasota, Florida
  • +4 more
Feb 10, 2023

Advanced or Metastatic Solid Tumors Trial in Worldwide (MK-1484, Pembrolizumab)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • MK-1484
  • Pembrolizumab
  • Sioux Falls, South Dakota
  • +6 more
Jan 25, 2023

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Advanced or Metastatic Solid Tumors Trial in Toronto, Genève, Bellinzona (MK-6598, Pembrolizumab)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Toronto, Ontario, Canada
  • +2 more
Jan 19, 2023

Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Non-Hodgkin Lymphoma
  • San Antonio, Texas
    NEXT Oncology
Jan 6, 2023

Advanced or Metastatic Solid Tumors Trial in Nashville, Houston, Villejuif (TAS0612)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Nashville, Tennessee
  • +2 more
Jan 5, 2023

Advanced or Metastatic Solid Tumors Trial in Gold Coast, Adelaide, Melbourne (MHB088C for Injection)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • MHB088C for Injection
  • Gold Coast, Queensland, Australia
  • +2 more
Jan 5, 2023

Advanced or Metastatic Solid Tumors Trial in Australia (AK119, AK104)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • AK119
  • AK104
  • Blacktown, New South Wales, Australia
  • +4 more
Jan 5, 2023

Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • W0101 - Cohort A1
  • +2 more
  • Toulouse, France
  • +2 more
Dec 19, 2022

Advanced or Metastatic Solid Tumors Trial in Tokyo (ONO-4578, ONO-4538)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • Nagoya, Aichi, Japan
  • +21 more
Dec 13, 2022

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022

Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • +8 more
  • Los Angeles, California
  • +5 more
Nov 29, 2022

Advanced or Metastatic Solid Tumors Trial in Australia, Korea, Republic of (HM97662)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • Adelaide, Australia
  • +7 more
Oct 24, 2022

Advanced or Metastatic Solid Tumors Trial in China, United States (MRG004A)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Orange, California
  • +8 more
Sep 6, 2022

Advanced or Metastatic Solid Tumors Trial in Worldwide (MK-3475A, Pembrolizumab, Pemetrexed)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • MK-3475A
  • +7 more
  • Santiago, Region M. De Santiago, Chile
  • +14 more
Aug 10, 2022

Advanced or Metastatic Solid Tumors Trial (DCBY02)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Aug 9, 2022

Advanced or Metastatic Solid Tumors Trial in Harbin (SYHX2001)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Aug 8, 2022

Advanced or Metastatic Solid Tumors Trial (HLX60 combined with HLX10)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • HLX60 combined with HLX10
  • (no location specified)
Aug 1, 2022